Denali Advisors’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $345K | Sell |
1,200
-303
| -20% | -$87.1K | 0.04% | 267 |
|
|
2025
Q1 | $463K | Buy |
1,503
+100
| +7% | +$30.8K | 0.05% | 239 |
|
|
2024
Q4 | $495K | Buy |
+1,403
| New | +$495K | 0.05% | 236 |
|
|
2021
Q3 | – | Sell |
-200
| Closed | -$36K | – | 325 |
|
|
2021
Q2 | $36K | Buy |
200
+100
| +100% | +$18K | 0.01% | 188 |
|
|
2021
Q1 | $17K | Sell |
100
-3,400
| -97% | -$578K | 0.01% | 293 |
|
|
2020
Q4 | $531K | Sell |
3,500
-800
| -19% | -$121K | 0.09% | 200 |
|
|
2020
Q3 | $434K | Sell |
4,300
-2,400
| -36% | -$242K | 0.09% | 211 |
|
|
2020
Q2 | $811K | Buy |
+6,700
| New | +$811K | 0.16% | 161 |
|
|
2019
Q4 | – | Sell |
-9,600
| Closed | -$766K | – | 354 |
|
|
2019
Q3 | $766K | Sell |
9,600
-76,900
| -89% | -$6.14M | 0.11% | 168 |
|
|
2019
Q2 | $6.75M | Buy |
86,500
+20,900
| +32% | +$1.63M | 1.01% | 41 |
|
|
2019
Q1 | $7.7M | Sell |
65,600
-27,400
| -29% | -$3.22M | 1.23% | 35 |
|
|
2018
Q4 | $10.1M | Buy |
+93,000
| New | +$10.1M | 1.69% | 26 |
|